Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration. (1/82)

Evaluation of CXCR4 inhibition in the prevention and intervention model of laser-induced choroidal neovascularization. (2/82)

Integrin activation or alpha 9 expression allows retinal pigmented epithelial cell adhesion on Bruch's membrane in wet age-related macular degeneration. (3/82)

Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. (4/82)

Patient selection criteria for pilot studies on amelioration of non-neovascular age-related macular degeneration. (5/82)

A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization. (6/82)

Clinical application of therapies targeting VEGF. (7/82)

Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. (8/82)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10